Is WELL Health a Buy?

Given its solid growth prospects, improving profitability, and attractive valuation, WELL Health could deliver superior returns over the next three years.

| More on:
doctor uses telehealth

Source: Getty Images

WELL Health Technologies (TSX:WELL) is a digital healthcare company focusing on developing technology and services that could aid healthcare professionals in delivering positive patient outcomes. The company has witnessed healthy buying this year, with its stock price rising by 84.4%. Its solid quarterly performances and continued acquisitions have boosted its financials.

Let’s assess whether WELL Health offers buying opportunities at these levels by looking at its third-quarter earnings and growth prospects.

WELL Health’s third-quarter performance

Last month, WELL Health reported an impressive third-quarter performance, with its top line growing by 27% to $251.7 million. Organic growth of 23% and acquisitions over the last four quarters drove its sales, while the divestments offset some of the growth. It had around 1.48 million patient visits and 2.24 patient interactions during the quarter, representing a year-over-year growth of 41% across both metrics. Amid the topline growth, its gross profits grew by 19%. However, its adjusted gross margin contracted by 150 basis points to 44.6% amid increased contributions from lower-margin recruiting revenue from the acquisition of CarePlus.

The digital healthcare company’s adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) grew 16% to $32.7 million. However, the adjusted EBITDA to WELL’s shareholders rose by 10% to $25.1 million. Its adjusted net income stood at $13 million, slightly improving from $12.9 million in the previous year’s quarter. The company generated $16.2 million of adjusted free cash flow during the quarter, supported by its comprehensive cost-cutting program, which it implemented earlier this year. Now, let’s look at its growth prospects.

WELL Health’s growth prospects

Given their accessibility, cost-effectiveness, and convenience, more people are adopting digital healthcare services. Technological advancements and improving internet penetration have also contributed to the rising popularity of virtual services, thus expanding the addressable market for WELL Health.

Meanwhile, the company continues to invest in advancing AI (artificial intelligence)-powered tech enablement for care providers, which could strengthen its position in the digital healthcare sector. The company’s acquisition pipeline looks solid, with 17 signed LOIs (letters of intent) and definitive agreements. Also, the company’s cost-cutting program would continue to improve its profitability.

Moreover, WELL Health has rebranded its subsidiary WELL Provider Solutions Group as WELLSTAR Technologies. This pure-play software-as-a-service (SaaS) technology company offers high-quality technology and services to around 37,000 healthcare providers to improve patient care. The company is also working on spinning out WELLSTAR, thus providing investors with an attractive investment opportunity in healthcare technology SaaS. It expects to complete the spinoff by the end of next year.

WELLSTAR recently acquired two healthcare-focused technology companies, which could contribute $15 million in annualized revenue, thus raising its 2025 pro forma revenue to $70 million. Also, its gross margins could remain above 80% while its EBITDA margin would be around 20%. Considering all these factors, I believe WELL Health’s growth prospects look healthy.

Investors’ takeaway

Despite the substantial increase in its stock price, WELL Health’s valuation looks attractive. Its next-12-month price-to-sales and NTM price-to-earnings multiples stand at 1.6 and 24.2, respectively. Given its solid growth prospects, improving profitability, and attractive valuation, I expect WELL Health to deliver superior returns over the next three years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Income and growth financial chart
Investing

2024 Market Surprises: Canadian Stocks That Outperformed Expectations

Did these stocks give you surprises this year? Consider the potential risks they bring before making any significant moves today.

Read more »

chip with the letters "AI" on it
Tech Stocks

The Smartest Growth Stock to Buy With $2,000 Right Now 

Investors seeking to buy the dip before the next up cycle should consider these cyclical chip stocks selling at a…

Read more »

Train cars pass over trestle bridge in the mountains
Dividend Stocks

What to Know About Canadian Transportation Stocks for 2025

Canadian transportation stocks could have a very interesting 2025, so here are stocks to watch and broader market concerns.

Read more »

telehealth stocks
Tech Stocks

The Ultimate Growth Stock to Buy With $1,000 Right Now

Well Health stock has rallied 87% this year, as the company continues on its path of record-breaking growth.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

Planning Ahead: Optimizing TFSA Contribution Room for 2025

$102,000 tax-free? Maximize your TFSA by 2025! Learn how to optimize contributions & investments.

Read more »

Start line on the highway
Stock Market

How Should a Beginner Invest in Stocks? Start With This Index Fund

Are you looking to start investing in Canada? Learn why holding an S&P 500 index fund is the best strategy…

Read more »

hand stacks coins
Dividend Stocks

These Are the Highest-Yielding Stocks on the TSX Right Now 

The recent correction in the TSX Composite Index has inflated dividend yields. These are the highest-yielding stocks on the TSX…

Read more »

Muscles Drawn On Black board
Investing

I Changed My Mind About Investing in Defence Stocks

Here's why I'm no longer bullish on defence contractors.

Read more »